Company
United StatesPublic company, NASDAQ: INGNInogen, Inc (NASDAQ: INGN), Plano, TX – FDA Inspections
Inspection records and compliance data for Inogen, Inc in Plano, Texas. 3 FDA inspections on record, 2 Form 483s, last inspected September 27, 2018. Publicly traded as NASDAQ: INGN.
Company Profile
This profile covers Inogen, Inc based in Plano, Texas, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected June 26, 2013. Last inspected September 27, 2018.
Most cited issue areas
- Investigation of device failures1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 27, 2018 | Not classified | Medical Devices & Rad Health | 1127095 |
| August 23, 2017 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1022883 |
| June 26, 2013 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 837168 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Inogen, Inc
Stock ticker
INGN
Exchange
NASDAQ
Share price
$6.83
Market cap
$181.3M
Price as of
November 6, 2026
FEI Number
3009843463
Address
600 Shiloh Rd, Plano, Texas 75074, United States
Country
United States
ID: 058b6461-ebda-4f36-af05-7b84a8efa0b3